IMMEDIATE PAST PRESIDENT, INDIAN PHARMACEUTICAL ASSOCIATION AND PRESIDENT, COMMONWEALTH PHARMACISTS ASSOCIATION
The IPA has led India’s pharmaceutical industry from its early conception in 1939 to its rise to become ‘The Pharmacy of the World’ today, and in this interview sets out its views for the industry with GBR.
Impala Terminals is expanding its services in sub Saharan Africa in tandem with the development of the mining industry and with the continents infrastructure developments.
GK Ancuabe graphite mine has expanded its capacity, offering an alternative to graphite from China and demonstrating that successful mining can be achieved in Mozambique.
Orion Minerals will be South Africa’s next copper and zinc producer with the Prieska project being a copper-predominant project. Full development is scheduled to begin in early 2020.
DIRECTOR – BUSINESS DEVELOPMENT, GLOBAL CLINICAL TRIALS
United States Biopharmaceuticals 2019
GCT is a CRO providing clinical development services for drugs and medical devices, with operations focused on Central and Eastern Europe, Russia and India.
MACIG 2025 - Mining in Africa Country Investment Guide
It is said that mining is a patient industry. Current demand projections are not. Demand for minerals deemed ‘critical’ is set to increase almost fourfold by 2030, according to the UN. Demand for nickel, cobalt and lithium is predicted to double, triple and rise ten-fold, respectively, between 2022 and 2050. The world will need to mine more copper between 2018 and 2050 than it has mined throughout history. 2050 is also the deadline to curb emissions before reaching a point of ‘no return.’ The pace of mineral demand and the consequences of not meeting it force the industry to act fast and take more risks. Mining cannot afford to be a patient industry anymore. The scramble for supply drives miners back to geological credentials, and therefore to places like the African Central Copperbelt.